p53: puzzle and paradigm - PubMed (original) (raw)

Review

. 1996 May 1;10(9):1054-72.

doi: 10.1101/gad.10.9.1054.

Affiliations

• PMID: 8654922
• DOI: 10.1101/gad.10.9.1054

Free article

Review

p53: puzzle and paradigm

L J Ko et al. Genes Dev. 1996.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• The tumor suppressor p53.
  Donehower LA, Bradley A. Donehower LA, et al. Biochim Biophys Acta. 1993 Aug 23;1155(2):181-205. doi: 10.1016/0304-419x(93)90004-v. Biochim Biophys Acta. 1993. PMID: 8357826 Review. No abstract available.
• p53: a cell cycle regulator activated by DNA damage.
  Selivanova G, Wiman KG. Selivanova G, et al. Adv Cancer Res. 1995;66:143-80. doi: 10.1016/s0065-230x(08)60253-5. Adv Cancer Res. 1995. PMID: 7793313 Review. No abstract available.
• Structural biology of the tumor suppressor p53.
  Joerger AC, Fersht AR. Joerger AC, et al. Annu Rev Biochem. 2008;77:557-82. doi: 10.1146/annurev.biochem.77.060806.091238. Annu Rev Biochem. 2008. PMID: 18410249 Review.
• Strategies for manipulating the p53 pathway in the treatment of human cancer.
  Hupp TR, Lane DP, Ball KL. Hupp TR, et al. Biochem J. 2000 Nov 15;352 Pt 1(Pt 1):1-17. Biochem J. 2000. PMID: 11062053 Free PMC article. Review.
• p53 and human cancer: the first ten thousand mutations.
  Hainaut P, Hollstein M. Hainaut P, et al. Adv Cancer Res. 2000;77:81-137. doi: 10.1016/s0065-230x(08)60785-x. Adv Cancer Res. 2000. PMID: 10549356 Review. No abstract available.

Cited by

• The regulation of telomerase in oncogenesis.
  Skvortzov DA, Rubzova MP, Zvereva ME, Kiselev FL, Donzova OA. Skvortzov DA, et al. Acta Naturae. 2009 Apr;1(1):51-67. Acta Naturae. 2009. PMID: 22649586 Free PMC article.
• A p53 transcriptional signature in primary and metastatic cancers derived using machine learning.
  Keshavarz-Rahaghi F, Pleasance E, Kolisnik T, Jones SJM. Keshavarz-Rahaghi F, et al. Front Genet. 2022 Aug 29;13:987238. doi: 10.3389/fgene.2022.987238. eCollection 2022. Front Genet. 2022. PMID: 36134028 Free PMC article.
• Codon 72 polymorphism (rs1042522) of TP53 is associated with changes in diastolic blood pressure over time.
  Reiling E, Lyssenko V, Boer JM, Imholz S, Verschuren WM, Isomaa B, Tuomi T, Groop L, Dollé ME. Reiling E, et al. Eur J Hum Genet. 2012 Jun;20(6):696-700. doi: 10.1038/ejhg.2011.240. Epub 2011 Dec 21. Eur J Hum Genet. 2012. PMID: 22189267 Free PMC article.
• Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.
  Webster KA, Discher DJ, Kaiser S, Hernandez O, Sato B, Bishopric NH. Webster KA, et al. J Clin Invest. 1999 Aug;104(3):239-52. doi: 10.1172/JCI5871. J Clin Invest. 1999. PMID: 10430605 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • HighWire

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal